(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...

Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its and partner Sandoz's favour over the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.

(Reuters) - GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once ...

LONDON (MarketWatch) -- Lung-disease patients taking GlaxoSmithKline PLC's GSK asthma inhaler Seretide have better survival benefits than those taking a rival product, according to a study published ...

Vectura Group said on Friday a British court had ruled in its and partner Sandoz's favour over the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates, clinicians may ...

Trump: US will strike Iran's power plants if Hormuz not open ...

In light of its recent CE Mark, Kraków, Poland-based respiratory health company FindAir will begin sales of its digital inhaler add-on to European consumers tomorrow, the company announced in a press ...